Atlas Trials

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Clinical trial NCT04276688 · COMPLETED

Trial details

NCT number
NCT04276688
Sponsor
The University of Hong Kong
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Novel Coronavirus Infection
Start date
2020-02-10
Primary completion
2020-03-30
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.